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Abstract
Introduction: The aim of the study was to assess whether neutrophil gelatinase-
associated lipocalin (NGAL) and cystatin C could reflect kidney function in
pregnant healthy women. 
Material and methods: The studies were performed on 130 healthy pregnant
women (n = 63, 3rd trimester; n = 21, 2nd trimester; n = 46, 1st trimester) and 
30 healthy female volunteers. Serum NGAL, cystatin C, IL-6, and hs-CRP were
assayed using commercially available kits. 
Results: Serum cystatin C rose steadily during the pregnancy, whereas NGAL
rose in the 2nd trimester, then decreased in the 3rd trimester. In univariate
analysis, NGAL correlated with serum cystatin C, number of pregnancies, white
blood cell count, total iron-binding capacity (TIBC), ferritin, and IL-6, and tended
to correlate with eGFR. In multiple regression analysis the only predictor of serum
NGAL was cystatin C. 
Conclusions: Serum NGAL in pregnancy might reflect subclinical inflammation
rather than kidney function. It seems that NGAL, similarly to cystatin C, is not
useful to monitor renal function in pregnancy.
Key words: NGAL, cystatin C, pregnancy, cytokines, IL-6, eGFR, kidney function,
creatinine.
Introduction
Normal pregnancy is characterized by profound changes in almost every
organ system to accommodate the demands of the fetoplacental unit. Normal
pregnancy is also characterized by increased renal perfusion, i.e. a rise in the
glomerular filtration rate (GFR) and renal blood flow. The increase in GFR can
be demonstrated within one month of conception and reaches a peak
approximately 40% to 50% above baseline levels by the end of the first
trimester [1]. Moreover, renal blood flow increases by 80% above non-pregnant
values. The glomerular hyperfiltration results in a normal reduction in the
plasma creatinine concentration to about 0.4 mg/dl to 0.5 mg/dl (35 mmol/l
to 44 mmol/l); thus, a “normal” level of 0.8 mg/dl (70 mmol/l) during
pregnancy represent a mild decline in renal function, possibly from some
underlying renal disease. It is well known that serum creatinine is an imperfect
marker to measure GFR. There has been interest in exploring other biomarkers
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for estimating renal function. The most promising
agent seems to be cystatin C [2]. The value of
neutrophil gelatinase-associated lipocalin (NGAL) was
highlighted as a novel biomarker of kidney function
[3]. Because of its small molecular size (25 kDa) and
resistance to degradation, NGAL is readily excreted
and detected in urine as cystatin C. Taking all these
data into consideration, the aim of the study was to
assess whether NGAL could reflect kidney function
in pregnant healthy women. We also assessed
correlations between NGAL, cystatin C, creatinine and
estimated GFR (eGFR) using 3 formulae.
Material and methods
We assessed kidney function in 130 healthy
pregnant women (n = 46, 1st trimester, n = 21, 2nd
trimester and n = 63, 3rd trimester) and 30 healthy
female volunteers (to establish the normal range for
NGAL). The inclusion criteria were: physiological,
uncomplicated pregnancy, no inflammation/infection,
no prior kidney disease. The exclusion criteria were:
complications of pregnancy (imminent abortion,
premature delivery, bleeding, cramps requiring
drugs/hospitalizations), history of kidney diseases,
anaemia, infection, comorbidities (diabetes,
hypertension, etc). Since NGAL is affected by kidney
function [3] we included only females with normal
kidney function (creatinine less than 1.2 mg/dl, eGFR
in the normal range of 90-120 ml/min). All the
subjects were informed about the aim of the study
and gave their consent. The study was approved by
the local Medical University Ethic Committee. Healthy
volunteers were recruited mainly from the medical
staff and their friends and families. We assessed
kidney function according to the simplified 
MDRD equation (eGFR = 186.3 × serum creatinine
(mg/dl)–1.14 × age–0.203 × 0.742 if female × 1.21 if Afro-
American) and Cockcroft-Gault formula (creatinine
clearance = [140-age] × body weight/serum creatinine
× 72 if female × 0.85) and new CKD-EPI formula [4]. 
Serum NGAL (ANTIBODYSHOP, Gentofte,
Denmark), cystatin C (Dade Behring, Marburg,
Germany), IL-6 (R&D, Abingdon, UK), hs-CRP
(American Diagnostica, Greenwich, CT, USA) were
assayed using commercially available kits. Complete
blood count, serum iron, total iron-binding capacity
(TIBC), ferritin, and creatinine were assayed by
means of standard laboratory methods in the
central laboratory. All tests were performed
according to manufacturers’ instructions by the
same person. ANOVA or Kruskal-Wallis ANOVA was
used in statistical analysis. 
Results
All the data are presented in Table I. We
observed a statistically significant fall in serum
Healthy volunteers 1st trimester  2nd trimester 3rd trimester
n = 30 n = 46 n = 21 n = 63
Age [years] 29.8 ±8.4 26.7 ±5.2 26.2 ±5.8 26.6 ±5.5
Number of pregnancies 1.5 ±0.9 3.2 ±1.8 1.8 ±1.6 1.7 ±0.9
Ht [%] 39.87 ±2.48 35.37 ±3.45* 33.39 ±2.19*** 33.12 ±3.71***
Hb [g/dl] 13.87 ±0.94 12.59 ±1.38 12.13 ±1.19* 11.06 ±1.41***
Erythrocyte count [× 1012/l] 4.24 ±0.29 4.02 ±0.36* 3.75 ±0.34*** 3.69 ±0.35***
Leukocyte count [× 1012/l] 5.53 ±1.61 7.96 ±1.88* 10.26 ±2.52*** 9.85 ±2.32***
Neutrophil count [× 1012/l] 4.87 ±3.87 5.56 ±1.79 6.98 ±2.14*** 7.32 ±2.38***
Platelet count [× 109/l] 241.45 ±44.55 239.32 ±61.01 240.45 ±51.45 210.24 ±47.91
NGAL [ng/ml] 18.34 ±4.65 19.96 ±24.16 38.85 ±25.08* 24.03 ±21.52
Cystatin C [mg/l] 0.82 ±0.18 0.81 ±0.19 0.86 ±0.22 1.24 ±0.37**
MDRD equation [ml/min] 99.78 ±14.42 116.88 ±17.6* 164.68 ±54.1*** 132.77 ±28.43***
Cockcroft-Gault formula [ml/min] 98.76 ±18.76 128.72 ±22.98* 182.75 ±56.54*** 172.05 ±39.22***
CKD-EPI formula [ml/min] 101.03 ±13.32 118.68 ±11.29* 133.24 ±11.78*** 123.22 ±14.58***
Creatinine [mg/dl] 0.77 ±0.14 0.66 ±0.09* 0.51 ±0.11* 0.61 ±0.13*
hsIL 6 [pg/ml] 2.26 ±2.02 5.61 ±2.85** 6.95 ±3.62*** 7.52 ±4.16***
hs-CRP [mg/ml] 1.74 ±0.52 2.71 ±1.88 4.21 ±2.54** 6.19 ±3.56***
Iron [µg/dl] 110.56 ±25.76 97.35 ±32.15 92.09 ±44.59 87.17 ±41.37*
TIBC [µg/dl] 328.98 ±84.31 359.12 ±77.58 323.81 ±70.84 514.99 ±87.62*
Ferritin [ng/dl] 30.22 ±17.43 27.63 ±19.52 38.31 ±34.68 28.66 ±27.82
Values given are means  ± SD, *p < 0.05, **p < 0.01, ***p < 0.001 vs. control group
Table I. Basal clinical and biochemical characteristics of the studied groups
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creatinine in the 2nd trimester together with a rise
in eGFR, when compared with the 1st trimester.
Serum cystatin C rose steadily during the pregnancy,
whereas NGAL rose in the 2nd trimester, then
decreased in the 3rd trimester. In pregnant females,
eGFR (all formulae) was significantly higher in the
2nd trimester when compared to the 1st and 3rd
trimesters. NGAL correlated with serum cystatin C
(r = 0.25, p < 0.05), number of pregnancies (r = 0.25,
p < 0.05), white blood cell count (r = 0.29, p < 0.01),
neutrophil count (r = 0.35, p < 0.01), TIBC (r = –0.21,
p < 0.05), ferritin (r = 0.36, p < 0.01), and IL-6 
(r = 0.23, p < 0.05), and tended to correlate with
eGFR. Serum cystatin C correlated with eGFR by
MDRD (r = –0.19, p < 0.05), white blood cell count
(r = 0.22, p < 0.05), neutrophil count (r = 0.33, 
p < 0.001), TIBC (r = 0.43, p < 0.001), IL-6 (r = 0.30,
p < 0.01), hs-CRP (r = 0.20, p < 0.05), number of
pregnancies (r = 0.45, p < 0.001), and NGAL 
(r = 0.25, p < 0.05) (Figure 1), and tended to
correlate with creatinine. In multiple regression
analysis the associate of serum NGAL was cystatin
C (beta value 0.84, p = 0.008), multiple adjusted 
r2 = 0.70, F = 2.99, p < 0.034, SE = 5.54. 
In multiple regression analysis, the associates of
cystatin C were NGAL (beta value –0.42, 
p = 0.00016), neutrophil count (beta value 0.58, 
p = 0.02), and IL-6 (beta value 0.34, p = 0.0019),
explaining 63% of the variations of cystatin C
concentration (F = 13.15, p < 0.000001, SE = 0.23). 
In healthy females, serum NGAL correlated with
age (r = 0.35, p < 0.05), serum creatinine (r = 0.47,
p < 0.01), eGFR (r = –0.59, p < 0.001), leukocyte
count (r = 0.36, p < 0.05), and cystatin C (r = 0.44,
p < 0.01).
Discussion
We have shown in our study that in pregnant
healthy females, NGAL did not reflect changes in
GFR during pregnancy. The only predictor of NGAL
concentration was cystatin C. The high rate of
filtration in pregnancy persists until term [1]. Serum
creatinine is an imperfect marker to measure GFR
because the total amount of creatinine in plasma
water, and therefore the plasma concentration, is
dependent on muscle mass, as well as some lesser
variables. When any single measurement of plasma
creatinine is compared to the whole range of
normal values, a marked reduction in renal function
(40% to 50%) is necessary before a rise in plasma
creatinine into the abnormal range is observed.
Efforts have been made to measure GFR from
a single measurement of creatinine using various
formulae to account for dependent variables.
However, accuracy has been poor when the
creatinine value has been in the normal or near
normal range. In recent years, there has been
interest in exploring other biomarkers for
estimating renal function. Inspection of reports
where cystatin C was compared to gold standard
markers has resulted in mixed reviews concerning
its potential usefulness [5]. In addition, cystatin is
affected by hyper- and hypothyroidism, and, as we
also observed in our study, has been correlated with
markers of inflammation (C-reactive protein) [6].
Although cystatin C appears to be more accurate
for the assessment of GFR than serum creatinine
in certain populations, whether or not
measurement of cystatin C levels will improve
patient care is unknown at present.
In contrast to the expected decrease in cystatin C
during the first and second trimesters, as observed
in the levels of plasma creatinine, the serum levels
of cystatin C increased in pregnancy [7]. Cysteine-
proteases are important in pregnancy for
implantation and trophoblast invasion of the
placenta. Cystatin C is the strongest extracellular
inhibitor of cysteine proteases and was originally
cloned from placental cDNA [8]. A study that
analysed expression of cystatin at the mRNA and
protein level in human placental tissue from normal
and pre-eclamptic pregnancies showed that
cystatin C was synthesized by the placenta and
secreted by trophoblast cells into the fetal and
maternal circulation [9]. Cystatin C played a role in
placentation, and placental production accounted
for the increase in cystatin C in normal pregnancy
and the further rise in pre-eclampsia [9]. However,
it is doubtful that cystatin C will be useful in
monitoring renal function in pregnancy.
In contrast to cystatin C, very little is known
about NGAL and the female reproductive tract. NGAL
has been found in amniotic fluid, cervical mucus,
and coloster [10]. However, the function of NGAL was
not revealed in this study. Lavery et al. [11] found
that urine NGAL was easily obtained in premature
infants and that it correlated significantly with both
birth weight and gestational age. 
Neutrophil gelatinase-associated lipocalin
belongs to the lipocalin family of proteins; NGAL
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Figure 1. Correlation between NGAL and cystatin C
in pregnant females
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was originally isolated from the supernatant of
activated human neutrophils, but it is also
expressed at a low level in other human tissues
including the kidney [12]. Neutrophil gelatinase-
associated lipocalin is synthesized systemically in
response to kidney damage followed by glomerular
filtration and tubular uptake; it could also be
produced locally by injured tubules. In our study
with pregnant women, both cystatin C and NGAL
correlated with markers of inflammation better
than with eGFR; they did not even show
a significant correlation with serum creatinine. In
a very recent paper, D’Anna et al. [13] reported that
NGAL serum concentrations in the pre-eclampsia
group were higher than in the control group, with
significant differences in each trimester. They
studied only 30 females in each group, and did not
study in detail kidney function and other
parameters. 
The strength of our study is simultaneous
measurement of serum NGAL and cystatin C.
However, there are also some limitations. This is
a single-centre, cross-sectional study, without
measurement of GFR. It was not possible to study
true GFR using either isotopic methods or insulin
clearance; therefore we estimated GFR from known
formulae. Similarly to cystatin C, although reference
ranges have been reported, there is no current
standard for serum NGAL measurements. In
addition, testing for NGAL is only available in
a limited number of laboratories using ELISA assay.
However, urinary and plasma assay enabling more
rapid measurement are under development. 
In conclusion, serum NGAL in pregnancy might
reflect subclinical inflammation rather than kidney
function. It seems that NGAL, similarly to cystatin C,
is not useful to monitor renal function in pregnancy.
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